VincentFBMorandEFMurphyKMackayFMarietteXMarcelliC. Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: A real issue, a clinical perspective. Annals of the Rheumatic Diseases2013; 72(2): 165–178.
2.
MokCCTsaiWCChenDYWeiJC. Immunogenicity of anti-TNF biologic agents in the treatment of rheumatoid arthritis. Expert Opin Biol Ther2016; 16(2): 201–211.
3.
VasooS. Drug-induced lupus: An update. Lupus2006; 15(11): 757–761.
4.
AtzeniFTalottaRSalaffiFCassinottiAVariscoVBattellinoMet al.Immunogenicity and autoimmunity during anti-TNF therapy. Autoimmun Rev2013; 12(7): 703–708.
5.
WetterDADavisMD. Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic. Mayo Clinic Proceedings2009; 84(11): 979–984.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
